Empire Financial Management Company’s Quest Diagnostics DGX Stock Holding History

Empire Financial Management Company’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,711	Closed	-$508K	–	205
2024 Q2	$508K	Sell	3,711 -754	-17%	-$103K	0.17%	142
2024 Q1	$594K	Sell	4,465 -212	-5%	-$27.5K	0.2%	131
2023 Q4	$645K	Buy	4,677 +87	+2%	+$11.4K	0.25%	100
2023 Q3	$559K	Sell	4,590 -249	-5%	-$33.2K	0.24%	105
2023 Q2	$680K	Sell	4,839 -23	-0.5%	-$3.17K	0.27%	91
2023 Q1	$688K	Buy	+4,862	New	+$696K	0.28%	93

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Empire Financial Management Company's DGX Position: Q3 2024 in Review

Empire Financial Management Company sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 3,711 shares — an estimated $508K sold.

Empire Financial Management Company first reported a position in DGX in Q1 2023 and held it in 6 quarters. The position peaked at $688K in Q1 2023. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

Empire Financial Management Company reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
Empire Financial Management Company sold 3,711 Quest Diagnostics shares in Q3 2024, an estimated $508K.
Empire Financial Management Company first reported a position in Quest Diagnostics in Q1 2023 and held it in 6 quarters.
Empire Financial Management Company's Quest Diagnostics position peaked at $688K in Q1 2023.
847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Empire Financial Management Company's 13F filing for Q3 2024, filed 18 Nov 2024.